India to Egypt: Lenvatinib Export Trade Route

The India to Egypt Lenvatinib corridor is one of India's established pharmaceutical export routes, with 17 shipments documented worth a combined $65.5K USD. The route is dominated by AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's lenvatinib manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $3.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with lenvatinib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 27.0%, placing it at rank #17 among India's top lenvatinib export destinations globally.

On the import side, key buyers of Indian lenvatinib in Egypt include TO THE ORDER OF'', ROYAL PHARMA COMPANY, ROYAL PHARMACEUTICALS L L FZ and 7 others. TO THE ORDER OF'' is the single largest importer with 2 shipments valued at $19.0K USD.

India's lenvatinib exports to Egypt are driven primarily by a handful of large-scale manufacturers. AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Egypt benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AL-ROYAL PHARMACEUTICAL PRIVATE LIMITED, HEALTHBIOTICS PRIVATE LIMITED, AARIA PHARMACEUTICALS PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $3.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as lentris 10mg (lenvatinib 10mg) and lenvatinib 10mg capsule(lentris 10mg) batch no.po240606a, mfg.dt.10/2024, exp.dt.09/2026, suggesting that buyers in Egypt tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF'' is the largest importer with 2 shipments worth $19.0K USD — representing 29% of all lenvatinib imports from India on this route. A total of 10 buyers are active on this corridor.